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Abstract
The aim of many studies in biomedicine is to infer
cause-effect relationships rather then simple as-
sociations. For instance, researcher might gather
data on dietary habits, and cognitive function in
an elderly population to determine which factors
affect cognitive decline and to predict the effects
of changes in diet on cognition. Finding answers
to questions where we want to know the outcome
after some other variable has been manipulated,
is the subject of causal inference. Inferring causal
effects from observational data is challenging and
requires making untestable assumptions about the
data-generating process. One essential assump-
tion is that of no unmeasured confounder. In com-
plex neuroimaging studies, we neither know all
potential confounders nor do we have data on
them. Thus, estimating a substitute confounder
would be desirable. While this is infeasible in gen-
eral, we will illustrate that by considering multiple
causes of interest simultaneously, we can leverage
the dependencies among them to identify causal
effects by means of a latent factor model. In our
experiments, we quantitatively evaluate the effec-
tiveness of our approach on semi-synthetic data,
where we know the true causal effects, and illus-
trate its use on real data on Alzheimer’s disease,
where it reveals important causes that otherwise
would have been missed.
1. Introduction
Most of us already use causal language in everyday life, e.g.,
when saying “I will fail the exam if I do not study”. Nev-
ertheless, we know that failing the exam is not absolutely
certain, but more likely, hence we draw our conclusion
merely from associations. In contrast, causal inference pro-
vides a principled statistical framework to answer questions
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about cause-effect relationships. In causal inference, we
consider one specific individual (termed unit) and a set of
actions (also called manipulations, interventions, treatments,
or causes) and want to know the outcome for each action.
We might want to know a specific person’s cognitive per-
formance whether that person underwent regular cognitive
training or not (Ngandu et al., 2015). This would allow us to
compare the outcome under both actions to determine the in-
dividual causal effect of cognitive training on cognition. In
practice, we can only observe one of the outcomes – the one
that corresponds to the actual action taken – all other out-
comes remain unobserved. Thus, it is generally impossible
to infer causal effects from observational data alone without
making untestable assumptions about the data-generating
process (Pearl, 2000). The gold standard to resolve this
issue is a randomized experiment, where each participant
is randomly assigned an action to ensure that the missing
outcome arises truly due to chance. In medical research,
such trials are usually laborious and in some cases unethical,
whereas observational data is often readily available. How-
ever, in an observational study assignment may not be truly
random but due to other factors. If those factors affect the
outcome that is being studied, we say there is confounding.
It is important to remember that what is or is not regarded as
a confounding variable is relative and depends on the goal
of the study. Consider a study on the cause of Alzheimer’s
disease (AD) where we find a high correlation between hav-
ing gray hair and AD, which may naïvly lead us to conclude
that gray hair causes AD. However, the observed correlation
between gray hair and AD is only due to a person’s age,
which renders the relationship between gray hair and AD
confounded. Therefore, one essential assumption in causal
inference is that of no unmeasured confounder. Otherwise,
if unobserved confounding is present, the observed data
distribution is compatible with many – potentially contra-
dictory – causal explanations, leaving us with no way to
differentiate between the true and false effect on the basis of
data. In this case, the causal effect is unidentifiable (Pearl,
2000).
Adjusting for known confounding variables is one method
that permits us to estimate causal effects in observational
studies. However, analyses across 15 neuroimaging stud-
ies revealed that considerable bias remains in volume and
thickness measurement after adjusting for age and gen-
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der (Wachinger et al., 2019). This result suggests that
additional unknown confounders do exist and hence the
assumption “no unmeasured confounder” is violated. While
scanner-related effects might contribute to it, it is unreal-
istic to assume all potential confounders are known and
have been recorded. Despite the importance of this topic,
there has been little prior work in neuroimaging. We be-
lieve recent theoretical advances in causal inference can be
of wide interest to the neuroimaging community to answer
important clinical questions.
In this paper, we focus on the problem of estimating causal
effects from observational neuroimaging data in the pres-
ence of unknown confounders. Modelling unknown con-
founders would alleviate the previously discussed problem
of knowing all confounding factors, and enable the estima-
tion of causal effects. While this is infeasible in general, we
will illustrate that by considering multiple causes of interest
simultaneously, we can leverage the dependencies among
them to identify causal effects. In our experiments, we quan-
titatively demonstrate the effectiveness of our approach on
semi-synthetic data, where we know the true causal effects,
and illustrate its use on real data on Alzheimer’s disease,
where our analyses reveal important causes that would oth-
erwise have been missed.
1.1. Related Work.
In contrast to our approach, all the previous works assume
that all confounding variables are known and have been
measured. The most common approach for confounding
adjustment is regress-out. In regress-out, the original mea-
surement (e.g. volume, thickness, or voxel intensity) is
replaced by the residual of a regression model fitted to es-
timate the original value from the confounding variables.
In (Dukart et al., 2011), the authors use linear regression
to account for age, which has been extended to addition-
ally account for gender in (Koikkalainen et al., 2012). A
non-linear Gaussian process (GP) model has been proposed
in (Kostro et al., 2014) to adjust for age, total intracranial
volume, sex, and MRI scanner. Fortin et al. (Fortin et al.,
2018) proposed a linear mixed effects model to account for
systematic differences across imaging sites. In (Snoek et al.,
2019), a linear regression is used to regress-out the effect of
total brain volume. In addition to the regress-out approach,
analyses can be adjusted for confounders by computing in-
stance weights, that are used in a downstream classification
or regression model to obtain a pseudo-population that is ap-
proximately balanced with respect to the confounders (Linn
et al., 2016; Rao et al., 2017). An instance-weighted sup-
port vector machine to adjust for confounding due to age
is proposed in (Linn et al., 2016). In (Rao et al., 2017),
weighted GP regression is proposed to account for gender
and imaging site effects.
2. Methods
2.1. Causal Effect
To denote causal quantities, we will use Pearl’s do-
calculus (Pearl, 2000). Given two disjoint sets of ran-
dom variables X and Y , P (y | do(x)) denotes the post-
intervention distribution of Y = y induced by the inter-
vention or cause X that sets it equal to x. Going back to our
example on cognitive decline, if X denotes whether cogni-
tive training was performed, and Y whether dementia was
diagnosed, then P (dementia | do(cognitive training)) gives
the proportion of individuals that would be demented un-
der the hypothetical situation in which cognitive training
was administered uniformly to the population. The central
question in causal inference is that of identification: Can
the post-intervention distribution P (y | do(x)) be estimated
from data governed by the observed joint distribution over
X , Y , and confounding variables U? Because we only ob-
served y for specific values of x and u, and not any possible
configuration, we can only attempt this by building upon
assumptions on the data-generating process.
Here, we consider a set of D causes, X1, . . . , XD, and want
to estimate the average causal effect (ACE) that a subset of
k < D causes have simultaneously on the outcome Y in the
presence of unobserved confounding:
E [Y | do(X1:k = x1:k)]− E [Y | do(X1:k = x′1:k)] , (1)
where x1:k and x′1:k are two distinct realizations of X1:k =
{X1, . . . , Xk} that are being compared. We base our
method on the causal diagram depicted in fig. 1. We assume
that the data-generating process is faithful to the graphi-
cal model, i.e., statistical independencies in the observed
data distribution imply missing causal relationships in the
graph (Spirtes et al., 2000). In particular, this implies that
there is a common unobserved confounder U that is shared
among all causes X and that there is no unobserved con-
founder that affects a single cause. If U would be observed
and satisfies the back-door criterion relative to X and Y ,
Pearl (2000) showed that the causal effect of X on Y is
identifiable and is given by P (y | do(x)) = ∫ P (y |X =
x, U = u) dP (u).
2.2. Estimating a Substitute Confounder
Since we do not have access to the actual confounder U ,
we want to find a substitute Z that can be estimated from
observed data. We assume the substitute confounding vari-
able Z is shared among all causes X1:D. In the context
of neuroimaging, where causes X are image-derived mea-
sures such as volume, this would imply that the unknown
confounder affects all brain regions and not just single
regions. This assumption is plausible, because common
sources of confounding such as scanner, protocol, age, and
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Figure 1. A: Causal graph with circles being random variables and arrows causal relationships. Filled circles are observed, transparent
circles are hidden. Y is the outcome of interest, X1, . . . XD the set of causes, U the actual, unknown confounder, and Z the substitute
confounder. B: Probabilistic principal component model. C: Bayesian probabilistic matrix factorization model.
gender affect the brain as a whole and not just individual re-
gions (Barnes et al., 2010; Stonnington et al., 2008). Based
on this assumption, we can exploit the fact that the con-
founder induces dependence among the causes.
From fig. 1 we can observe that given a substitute
z, the causes X1:D become conditionally independent:
P (x1, . . . xD | z) =
∏D
d=1 P (xd | z). For a K-dimensional
substitute confounder z, the joint probability of the causes
is thus
P (x1, . . . , xD) =
∫ D∏
d=1
P (xd | z)P (z) dz. (2)
The key realization of our proposed method is that the joint
probability (2), which is derived solely from the causal
graph in fig. 1, has the same form as the joint distribu-
tion of a latent factor model such as probabilistic principal
component analysis (PPCA, Tipping & Bishop (1999)) or
probabilistic matrix factorization (BPMF, Salakhutdinov &
Mnih (2008)), depicted in fig. 1. Therefore, we can utilize
this connection to estimate a substitute confounder Z for
the unobserved confounder U via a latent factor model: if a
latent factor model can accurately represent all causes, its
latent representation is a suitable substitute confounder.
Wang & Blei (2019) showed that obtaining a substitute z for
the unobserved confounder by a probabilistic latent factor
model allows us to identify causal quantities under certain
assumptions. In particular, the ACE of a subset of causes
can be estimated by
E [Y | do(X1:k = x1:k)]− E [Y | do(X1:k = x′1:k)]
=
∫
E [Y |X1:k = x1:k, z] dP (z)
−
∫
E [Y |X1:k = x′1:k, z] dP (z). (3)
Thus, we can estimate the ACE by treating the substitute
confounder zˆ = E [Z |X1:D = x1:D] as if it were observed
(the expectation is over the factor model’s parameters).
Estimation. Let X = (x1, . . . ,xN )> ∈ RN×D be the
matrix of D observed causes for N instances, then the full
procedure to compute (3) is as follows. First, fit a probabilis-
tic factor model to the observed causes X and check that it
captures the joint distribution (2) well (see next section). If
the check passes, compute the substitute confounder zˆi for
i = 1, . . . , N . Next, fit a regression model to the observed
causes and substitute confounders to estimate E [Yi |xi, zˆi].
Apply the fitted model to the observed data and substitute
confounders with the first k features set to x1:k for all in-
stances, and compute the average prediction. This yields the
first term in (3). Do the same for the second term, but set
the first k features to x′1:k. The difference between both is
the ACE of X1:k on Y .
Assumptions. The equality in (3) holds under the follow-
ing assumptions (Wang & Blei, 2019, Theorem 7): (i) the
causes assigned to any instance have no effect on the out-
comes of the other instances (stable-unit-treatment-value
assumption (Rubin, 1980)), (ii) P (X1 . . . , Xk |Z) > 0
for any subset, such that the joint probability (2) is always
non-zero (positivity), and (iii) the latent factor model can
estimate the substitute confounder with consistency, i.e.,
deterministicly, as the number of causes grows large. Note,
that the latter assumption does not imply that we need to
find the true confounder, just a deterministic bijective trans-
formation of it (Wang & Blei, 2019).
2.3. Choosing a Latent Factor Model
The assumptions above enforce certain properties on the
latent factor model. First of all, it needs to be probabilistic.
Here, we explore PPCA (Tipping & Bishop, 1999), and
BPMF (Salakhutdinov & Mnih, 2008), which are summa-
rized in fig. 1. The positivity assumption (ii) holds for PPCA
and BPMF, because both model continuous variables as a
normal distribution with the mean determined by the latent
representation, and the normal distribution is non-zero ev-
erywhere. To satisfy assumption (iii), we need to ensure the
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Table 1. Root mean squared errors of effects estimated by logistic regression compared to the true causal effects on semi-synthetic data
(νε = 0.1). Oracle is the error when including the true confounder, BPMF and PPCA when including a substitute confounder. ∆BMPF is
the signed difference between the ‘Non-causal’ and the BMPF column, and ∆PPCA the same for PPCA.
νx/νz Non-causal Oracle BPMF PPCA ∆BPMF ∆PPCA
10/1 1.932 1.814 1.822 1.993 0.109 -0.061
5/1 2.012 1.847 1.850 2.019 0.162 -0.007
4/1 1.977 1.818 1.856 2.039 0.120 -0.062
3/1 1.990 1.854 1.878 2.030 0.112 -0.040
5/2 1.950 1.811 1.915 2.018 0.035 -0.069
5/3 2.031 1.854 1.907 2.063 0.123 -0.032
3/2 2.020 1.852 1.907 2.045 0.113 -0.025
1/1 2.019 1.873 1.930 2.052 0.089 -0.033
2/3 2.044 1.817 1.911 2.104 0.134 -0.059
3/5 2.050 1.849 1.946 2.110 0.104 -0.060
2/5 2.080 1.849 1.957 2.113 0.123 -0.033
1/3 2.102 1.875 1.983 2.164 0.119 -0.062
1/4 2.142 1.914 2.028 2.177 0.114 -0.034
1/5 2.147 1.910 2.012 2.159 0.135 -0.013
1/10 2.163 1.899 2.034 2.191 0.129 -0.028
factor model estimated from the observed causes captures
the joint distribution (2) well. We can employ posterior
predictive checking to quantify how well the factor model
fits the data (Gelman et al., 2014, ch. 6). The idea is that
simulated data generated under the factor model should look
similar to observed data. First, we hold-out a randomly se-
lected portion of the observed causes, yielding Xobs to fit
the factor model, and Xholdout for model checking. Next, we
draw simulated data from the joint posterior predictive distri-
bution. Let θ be the vector of parameters of the factor model,
including the substitute confounder z, then P (xsimi |xobsi ) =∫
P (xsimi | θ)P (θ |xobsi ) dθ. If there is a systematic differ-
ence between the simulated and the held-out data, we can
conclude that the latent model does not represent the causes
well. We use the expected negative log-likelihood as test
statistic: T (xi) = Eθ
[− log p(xi | θ )|xobsi ] . From it, we
can compute the Bayesian p-value pB , defined as the prob-
ability that the simulated data is more extreme than the
observed data (Gelman et al., 2014): pB = P (T (xsimi ) ≥
T (xholdouti ) |xobsi ). Wang & Blei (2019) suggested to use
pB > 0.1 to ensure assumption (iii) holds. We estimate
pB by drawing xsimi repeatedly from the posterior predic-
tive distribution for each i = 1, . . . , N and computing the
proportion for which T (xsimi ) ≥ T (xholdouti ).
3. Experiments
3.1. Semi-synthetic Data
In our first experiment, we evaluated how well causal ef-
fects can be recovered from the data when using no con-
founder, the actual confounder (oracle), and substitute con-
founders computed by PPCA and BPMF. We used T1-
weighted magnetic resonance imaging brains scans from
N = 10,824 subjects from UK Biobank (Miller et al., 2016).
From each scan, we extracted 29 volume measurements with
FreeSurfer 5.3 (Fischl, 2012) and created synthetic binary
outcomes. For each instance, we generated one confounding
variable zi by assigning individuals to clusters with varying
percentages of positive labels. First, we obtained the first
two principal components across all volumes, scaled indi-
vidual scores to [0; 1], and clustered the projected data into
4 clusters using k-means. Each cluster was assigned a differ-
ent zi ∈ {1, 2, 3, 4} and scale σk of the noise term. Causal
effects follow a sparse normal distribution (Nsparse), where
all values in the 20–80th percentile range are zero, hence
only a small portion of volumes have a non-zero causal
effect. Let νx, νz , and νε = νx − νz denote how much vari-
ance can be explained by the causal effects, confounding
effects, and the noise, respectively, then for the i-th instance
in cluster k, we generated outcome yi as:
yi ∼ Bernoulli(pi),
pi = expit(β0 + xiβ
√
νxσ
−1
x + zi
√
νzσ
−1
z + εi
√
νεσ
−1
ε ),
βj ∼ Nsparse(0, 0.5), εi ∼ N (0, σk),
σk ∼ InvGamma(3, 1),
where σx, σz , and σε are standard deviations with respect
to xiβ, zi, and εi for i = 1, . . . , N . Finally, we chose β0
to obtain a roughly equal ratio between the positive and
negative class.
Both latent factor models passed the posterior predictive
check with pB = 0.188 (BPMF) and pB = 0.810 (PPCA),
despite that the true data generation model differs. Table 3
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shows the root mean squared error (RMSE) with respect to
the true causal effect across 1,000 simulations for various
configurations for νx, νz , and fixed νε = 0.1 (more results
are in the supplementary materials). As expected, by ignor-
ing confounding (first column), the RMSE increases as the
contribution of the confounding effect increases (higher νz).
Results also show that there is a cost to using a substitute
confounder: using the actual confounder (oracle) leads to a
lower RMSE. Considering the improvement relative to the
non-causal model, we observe a gain when using BPMF
substitute confounders but not for PPCA.
3.2. Real-world Data
In our experiment on real data, we study the causal effect
of different AD pathologies and ApoE on the widely used
Alzheimer’s Disease Assessment Scale Cognitive Subscale
13 (ADAS) score, which assesses the severity of cognitive
symptoms of dementia (Mohs et al., 1997). ADAS ranges
between 0 and 85 with higher values indicating a higher cog-
nitive decline. To exclude factors of impairment for reasons
other than AD, we employ the ATN classification scheme
(amyloid deposition, pathologic tau, and neurodegenera-
tion), which classifies patients into one of eight distinct
pathological groups (Jack et al., 2018). We selected pa-
tients with normal pathology (A-/T-/N-) and those with
AD pathology (A+/T+/N+, A+/T+/N-). After removal of
highly correlated volume measurements, we retained 19
from which we computed a substitute confounder using
BPMF, as results on semi-synthetic data indicated its effec-
tiveness. To estimate the ACE (3), we converted ADAS to
proportions in the interval (0, 1) and used a Beta regression
model for prediction (Ferrari & Cribari-Neto, 2004). We
also included known clinical markers age, gender, ApoE,
and years of education for estimating causal effects. We
randomly split the data into 448 subjects for training and 49
for evaluation. All data was obtained from the Alzheimer’s
Disease Neuroimaging Initiative (Jack et al., 2008).
We used 2 substitute confounders and checked that BPMF
passed the posterior predictive check with pB = 0.184.
The biggest change in effect size, compared to the non-
causal model ignoring confounding, is the corpus callosum
volume (see fig. 2). In the non-causal model, the estimated
effect size is insignificant with the 80% credible interval
being almost equally distributed across both sides of the
zero. After including substitute confounders, a significant
negative association between corpus callosum volume and
ADAS is found. This is an interesting finding, since previous
studies found atrophy of corpus callosum to be a marker of
the progressive interhemispheric disconnection in AD (see
e.g. Delbeuck et al. (2003) for an overview). An analysis
based on the non-causal model would have missed this
cause.
Non-causal
BPMF
-0.10 -0.05 0.00
Figure 2. Mean coefficient (log-odds ratio) and 80% credible inter-
val of corpus callosum central volume.
Table 2. Average causal effect of ATN and ApoE status on ADAS.
x x′ Non-Causal BPMF
A+/T+/N+ A-/T-/N- 56.485 55.830
A+/T+/N- A-/T-/N- 40.977 40.530
A+/T+/N+ A+/T+/N- 29.534 29.147
Apo-ε4/ε4 Apo-ε3/ε3 2.553 2.532
Apo-ε3/ε4 Apo-ε2/ε2 -0.518 0.062
Next, we estimated the ACE of different AD pathologies
(see table 2). As expected, for the most extreme transition
from A-/T-/N- to A+/T+/N+, the estimated causal effect is
the largest, but is slightly reduced after including substitute
confounders. These values match the range observed for pa-
tients diagnosed with Alzheimer’s disease (Raghavan et al.,
2012). Finally, we focus on the ACE of ApoE. They are con-
siderably lower, with the highest being homozygous Apo-
ε3 (most common type) compared to homozygous Apo-ε4
(high risk type). When considering the effect from homozy-
gous Apo-ε2 (low risk type) to heterozygous Apo-ε3/ε4,
the effect of Apo-ε2 flips from being harmful to protective
after inclusion of substitute confounders. Studies on the
genetics of AD have found that the Apo-ε2 allele is indeed
protective of AD, therefore only the estimated effect with
substitute confounder agrees with clinical findings (Corder
et al., 1994). Our results show that if causal effects are large,
as in the case of ATN, the difference in estimated causal
effects is minor. However, if causal effects are small, as in
the case of corpus callosum volume and Apo-ε2, accounting
for unknown confounders does reveal clinically validated
effects that would have been missed with the non-causal
model.
4. Conclusion
Most neuroimaging studies are subject to various sources
of confounding, but usually we neither know all of them
nor do we have data on them. To alleviate this problem,
we proposed a latent factor model approach to estimate
causal effects from observational data in the presence of
unknown confounders. We showed in experiments on semi-
synthetic data that by including a substitute confounder, we
can recover causal effects more accurately than a model
that ignores confounding. Analyses on real data concerning
Alzheimer’s disease revealed that including substitute con-
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founders can reveal important causes of cognitive decline
that otherwise would have been missed.
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Table 3. Root mean squared errors of effects estimated by logistic regression compared to the true causal effects on semi-synthetic data
with νε = 0.2 and νε = 0.3. Oracle is the error when including the true confounder, BPMF and PPCA when including a substitute
confounder. ∆BMPF is the signed difference between the ‘Non-causal’ and the BMPF column, and ∆PPCA the same for PPCA.
νε νx/νz Non-causal Oracle BPMF PPCA ∆BPMF ∆PPCA
0.2 10/1 1.944 1.820 1.833 1.964 0.111 -0.021
5/1 1.963 1.822 1.829 2.011 0.133 -0.049
4/1 1.986 1.832 1.881 2.020 0.105 -0.034
3/1 1.933 1.786 1.894 1.959 0.039 -0.027
5/2 1.954 1.841 1.845 1.986 0.109 -0.032
5/3 1.976 1.863 1.887 2.027 0.089 -0.052
3/2 1.996 1.822 1.868 2.035 0.128 -0.039
1/1 1.998 1.858 1.911 2.017 0.087 -0.019
2/3 1.999 1.810 1.890 2.040 0.109 -0.041
3/5 1.994 1.827 1.896 2.027 0.098 -0.033
2/5 2.008 1.799 1.895 2.042 0.113 -0.033
1/3 2.049 1.829 1.916 2.051 0.132 -0.002
1/4 2.062 1.837 1.925 2.079 0.137 -0.017
1/5 2.054 1.848 1.970 2.090 0.084 -0.036
1/10 2.082 1.876 1.968 2.118 0.114 -0.036
0.3 10/1 1.897 1.781 1.797 1.919 0.100 -0.021
5/1 1.887 1.757 1.820 1.930 0.067 -0.043
4/1 1.903 1.800 1.796 1.945 0.108 -0.042
3/1 1.915 1.815 1.848 1.953 0.067 -0.038
5/2 1.957 1.838 1.856 2.000 0.101 -0.043
5/3 1.932 1.803 1.833 1.991 0.099 -0.059
3/2 1.928 1.779 1.819 1.971 0.109 -0.043
1/1 1.979 1.830 1.907 2.033 0.072 -0.054
2/3 1.961 1.796 1.855 1.991 0.105 -0.030
3/5 1.975 1.780 1.868 2.026 0.107 -0.051
2/5 1.965 1.797 1.862 1.996 0.103 -0.032
1/3 1.981 1.784 1.872 2.021 0.108 -0.040
1/4 2.018 1.827 1.899 2.007 0.119 0.011
1/5 1.997 1.799 1.932 2.043 0.066 -0.046
1/10 2.045 1.859 1.951 2.086 0.094 -0.042
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Figure 3. Mean coefficient (log-odds ratio) and 80% credible interval of all features on ADNI data.
